Riskpilot← Back to searchSign inGet full accessPT Stabilisation AB
ABActiveOrg 5568323421Pirgatan 13Research and experimental development on natural sciences and engineering · NACE 7210Est. 20100 employees
Revenue 2025
SEK 0
EBITDA margin
—
+98% vs 2024
Equity ratio
27.2%
Financial strength
Net profit 2025
SEK -69K
+45% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +98% |
| Net profit | SEK -69K | +45% |
| Total assets | SEK 318K | -13% |
| Equity | SEK 86K | +57% |
| Employees | 0 | — |
Legal name
PT Stabilisation AB
Org number
5568323421
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14 december 2010
Share capital
SEK 110 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicin- och medicinteknisk utveckling, med huvudsaklig inriktning på neurofysiologi, och därmed förenlig verksamhet.
Address
Pirgatan 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −9 | −14 | −14 | −12 | −15 | −15 | −94 | −54 | −107 | −67 | −2 |
| Depreciation & amort. | −137 | −331 | −234 | −234 | −234 | −102 | −78 | −78 | −78 | −48 | −48 |
| EBIT | −146 | −345 | −248 | −246 | −249 | −117 | −172 | −132 | −185 | −115 | −50 |
| Net financials | −13 | −13 | −13 | −14 | — | — | −1 | −2 | −6 | −9 | −19 |
| Profit before tax | −159 | −358 | −262 | −260 | −249 | −117 | −174 | −134 | −192 | −124 | −69 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| Net profit | −159 | −358 | −262 | −260 | −249 | −117 | −174 | −134 | −192 | −124 | −69 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 052 | 1 707 | 1 449 | 1 203 | 964 | 952 | 550 | 483 | 398 | 368 | 318 |
| Equity | 1 510 | 1 152 | 890 | 630 | 381 | 264 | 254 | 221 | 129 | 55 | 86 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 542 | 555 | 559 | 573 | 583 | 688 | 296 | 263 | 269 | 313 | 232 |
| Total debt | 542 | 555 | 559 | 573 | 583 | 688 | 296 | 263 | 269 | 313 | 232 |
EBITDA margin
-150700.0%
This company
15.8%
Market median
-953897% vs market
20152025
Equity ratio
27.2%
This company
38.2%
Market median
-29% vs market
20152025
Return on equity
-79.4%
This company
18.4%
Market median
-532% vs market
20152025
Net profit margin
-6863100.0%
This company
8.1%
Market median
-84729730% vs market
20152025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152025
Debt / equity
2.68×
This company
0.62×
Market median
-332% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KA Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Neuronano AB | Company | 75.0% | 75.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Neuronano AB
PT Stabilisation AB Board members of PT Stabilisation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Anders Håkansson | Chief Auditor | 0 companies |
| Karin Ida Emelie Gustafsson | Deputy Board Member | 0 companies |
| Per-Anders Karl Johansson | Board of Directors | 0 companies |